The University of Oxford and Oxford University Hospital lost about $11.1 million, and Chelsea and Westminster Hospital NHS Foundation Trust lost around $6.5 million when Sensyne Health’s stock prices dropped earlier this year. Both hospitals received company equity in exchange for patient data.
Sensyne Health aimed to develop an artificial technology-driven platform to accelerate new medicine discovery. Several hospitals signed an agreement with Strategic Research Agreements to share millions of deidentified patient health records with the company in exchange for shares.
Both hospitals were given around $6 million worth of equity stake in Sensyne between 2017 and 2018.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
